BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 29150348)

  • 1. De novo head and neck cancer arising in solid organ transplantation recipients: The Asan Medical Center experience.
    Park MJ; Roh JL; Choi SH; Nam SY; Kim SY; Lee YS
    Auris Nasus Larynx; 2018 Aug; 45(4):838-845. PubMed ID: 29150348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonmelanoma skin cancer of the head and neck region in solid organ transplant recipients.
    Ritter A; Bachar G; Feinmesser R; Shpitzer T; Popovtzer A; Rabinovics N
    Head Neck; 2019 Feb; 41(2):374-380. PubMed ID: 30549347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the incidence of de novo solid malignancies after heart transplantation to that in the general population.
    Kellerman L; Neugut A; Burke B; Mancini D
    Am J Cardiol; 2009 Feb; 103(4):562-6. PubMed ID: 19195521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased incidence of early de novo cancer in liver graft recipients treated with cyclosporine: an association with C2 monitoring and recipient age.
    Tjon AS; Sint Nicolaas J; Kwekkeboom J; de Man RA; Kazemier G; Tilanus HW; Hansen BE; van der Laan LJ; Tha-In T; Metselaar HJ
    Liver Transpl; 2010 Jul; 16(7):837-46. PubMed ID: 20583092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High frequency and mortality of head and neck malignancy in organ transplant recipients in Ireland - A national cohort study.
    Conlon E; Fitzgerald C; Hintze J; Elhassan EAE; Sexton DJ; O'Leary E; O'Kelly P; O'Neill JO; Egan J; Houlihan DD; Murray D; McCormick PA; Morris PG; Raghallaigh SN; Little D; Conlon PJ; Moloney FJ; O'Neill JP
    Am J Otolaryngol; 2023; 44(4):103827. PubMed ID: 36933332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer of the head and neck region in solid organ transplant recipients.
    Rabinovics N; Mizrachi A; Hadar T; Ad-El D; Feinmesser R; Guttman D; Shpitzer T; Bachar G
    Head Neck; 2014 Feb; 36(2):181-6. PubMed ID: 23554129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Head and neck cancer in transplant recipients.
    Deeb R; Sharma S; Mahan M; Al-Khudari S; Hall F; Yoshida A; Schweitzer V
    Laryngoscope; 2012 Jul; 122(7):1566-9. PubMed ID: 22473466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National survey of de novo malignancy after solid organ transplantation in Japan.
    Miyazaki T; Sato S; Kondo T; Kusaka M; Gotoh M; Saiki Y; Ono M; Kokudo N; Enosawa S; Satoh S; Soeda E; Furukawa H; Kobayashi E; Nagayasu T
    Surg Today; 2018 Jun; 48(6):618-624. PubMed ID: 29380136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Squamous cell carcinoma of the head and neck in solid organ transplant recipients.
    Preciado DA; Matas A; Adams GL
    Head Neck; 2002 Apr; 24(4):319-25. PubMed ID: 11933172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors.
    Kelly DM; Emre S; Guy SR; Miller CM; Schwartz ME; Sheiner PA
    Cancer; 1998 Sep; 83(6):1237-43. PubMed ID: 9740091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De Novo Head and Neck Cancer After Liver Transplant With Antibody-Based Immunosuppression Induction.
    Graham RC; Mella JS; Mangus RS
    Transplant Proc; 2018 Dec; 50(10):3661-3666. PubMed ID: 30577252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De novo thyroid cancer following solid organ transplantation-A 25-year experience at a high-volume institution with a review of the literature.
    Kluijfhout WP; Drake FT; Pasternak JD; Beninato T; Mitmaker EJ; Gosnell JE; Shen WT; Suh I; Freise CE; Duh QY
    J Surg Oncol; 2017 Feb; 115(2):105-108. PubMed ID: 28054345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonmelanoma Skin Cancers in Solid-Organ Transplant Recipients: A Single Center Experience.
    Albayati A; Ozkan B; Eyuboglu AA; Uysal AC; Markal Ertas N; Haberal M
    Exp Clin Transplant; 2018 Mar; 16 Suppl 1(Suppl 1):95-100. PubMed ID: 29528001
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Manzia TM; Angelico R; Gazia C; Lenci I; Milana M; Ademoyero OT; Pedini D; Toti L; Spada M; Tisone G; Baiocchi L
    World J Gastroenterol; 2019 Sep; 25(35):5356-5375. PubMed ID: 31558879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal Trends of De Novo Malignancy Development After Heart Transplantation.
    Youn JC; Stehlik J; Wilk AR; Cherikh W; Kim IC; Park GH; Lund LH; Eisen HJ; Kim DY; Lee SK; Choi SW; Han S; Ryu KH; Kang SM; Kobashigawa JA
    J Am Coll Cardiol; 2018 Jan; 71(1):40-49. PubMed ID: 29301626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periocular Skin Cancer in Solid Organ Transplant Recipients.
    Perry JD; Polito SC; Chundury RV; Singh AD; Fritz MA; Vidimos AT; Gastman BR; Koyfman SA
    Ophthalmology; 2016 Jan; 123(1):203-8. PubMed ID: 26520170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cumulative incidence and risk factors for cutaneous squamous cell carcinoma metastases in organ transplant recipients: The Skin Care in Organ Transplant Patients in Europe-International Transplant Skin Cancer Collaborative metastases study, a prospective multicenter study.
    de Jong E; Genders R; Harwood CA; Green AC; Plasmeijer EI; Proby C; Geissler E; Ferrándiz-Pulido C; Ducroux E; Euvrard S; Geusau A; Jahn-Bassler K; Borik-Heil L; Rácz E; Nägeli M; Hofbauer GFL; Piaserico S; Russo I; Mackintosh L; Borges-Costa J; Angeliki-Gkini M; Zavattaro E; Savoia P; Imko-Walszuk B; Dębska-Slizień A; Garmyn M; van Kelst S; Ricar J; Cetkovska P; Matin R; Güleç AT; Seçkin D; Anene CA; Oliveira WRP; Rademaker M; Goeman J; van Geloven N; Ruiz E; Murad F; Karn E; Schmults CD; Bouwes Bavinck JN
    J Am Acad Dermatol; 2024 Jun; 90(6):1200-1209. PubMed ID: 38301923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Head and neck cancer in cardiothoracic transplant recipients.
    Pollard JD; Hanasono MM; Mikulec AA; Le QT; Terris DJ
    Laryngoscope; 2000 Aug; 110(8):1257-61. PubMed ID: 10942122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation.
    Saigal S; Norris S; Muiesan P; Rela M; Heaton N; O'Grady J
    Liver Transpl; 2002 May; 8(5):482-7. PubMed ID: 12004349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammalian target of rapamycin inhibition after solid organ transplantation: can it, and does it, reduce cancer risk?
    Bhat M; Watt KD
    Clin Transplant; 2015 Jul; 29(7):654-63. PubMed ID: 26094583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.